Skip to main content

Table 3 Correlations (Rp) between the HRneg/Tneg and IR-7 prognostic indices with T- and B-lymphocyte gene signatures in the training and validation tumor cohorts

From: A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

 

Training cohort (n= 199)

Validation cohort (n= 75)

 

HRneg/Tneg

IR-7

HRneg/Tneg

IR-7

Lymphocyte-specific signatures

Rp

P value

Rp

P value

Rp

P value

Rp

P value

T-cell signature

-0.31

1.18 × 10-5

-0.65

< 2.2 × 10-16

-0.41

2.83 × 10-4

-0.62

3.439 × 10-9

T-cell co-receptor components

-0.39

9.28 × 10-9

-0.73

< 2.2 × 10-16

-0.42

1.78 × 10-4

-0.66

7.888 × 10-11

B-cell signature

-0.33

2.74 × 10-6

-0.89

< 2.2 × 10-16

-0.43

1.20 × 10-4

-0.77

9.07 × 10-16

B-cell surface co-receptor/marker

-0.15

2.94 × 10-2

-0.63

< 2.2 × 10-16

-0.34

2.60 × 10-3

-0.79

< 2.2 × 10-16

  1. HRneg, hormone receptor-negative; IR-7, immune response signature with 7-gene immune response module; Rp, Pearson correlation coefficient; Tneg, triple-negative.